Page 2 - Core Inc News Today

A consumer study reveals that a handheld vagus nerve stimulator not only enhances sleep quality and extends sleep duration for many users.

ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. ECOR, a commercial-stage bioelectronic medicine and wellness company, today announced the…

ElectroCore, Inc. (NASDAQ:ECOR – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 17,000 shares, an increase of 6.3% from the February 29th total of 16,000 shares. Based on an average daily volume of 14,600 shares, the short-interest ratio is […]

ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness comp...

We’re excited to gather businesses, organizations, and individuals from throughout Tehama County! Join us on March 7th from 8 a.m. to noon at the RHC Event Center for the first-ever “Elevate & Inspire Business Summit”. Hosted by the Red Bluff Chamber of Commerce, this Business Summit promises to be an amazing gathering of business leaders and […]

Contango Ore Inc is pleased to announce that the company will be presenting at Red Clouds Pre-PDAC 2024 Mining Showcase. We invite our shareholders and all interested parties to join us. The...

ElectroCore (NASDAQ:ECOR – Get Free Report) and Cochlear (OTCMKTS:CHEOF – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Valuation and Earnings This table compares electroCore and Cochlear’s revenue, […]

/PRNewswire/ -- The "Neuromodulation Devices Market Report 2024-2034" has been added to ResearchAndMarkets.coms offering. Revenue for the neuromodulation...

The global vagus nerve stimulation market size is anticipated to register a considerable CAGR of over 10% during the forecast period from 2024 to 2030.

ROCKAWAY, N.J., Dec. 26, 2023 -- electroCore, Inc. , a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United...